1. Varadhachary G, Spector Y,  et al. Prospective gene signature study using microRNA to prdict the tissue of origin (ToO) in patients with cancer of the unknown primary (CUP). Clin Cancer Res. 17(12)
2.  Mueller W, Spector Y, Edmondson T et al. Accurate classification of metastatic brain tumors using a novel microRNA-based test. The Oncologist. 2011; 16: 165-174
3. Chajut A, Rosenwald S, Edmondson T, et al. Development and validation of a second generation microRNA-based assay for diagnosing tumor tissue origin. AACR. 2011
4. Chajut A, Aharonov R, Rosenwald S, et al. A second generation microRNA-based assay for diagnosing tumor tissue origin. ASCO 2011.
5. Rosenwald Shai, Gilad Shlomit, et al.  Validation of micro-RNA based qRT-PCR test for accurate identification of tumor tissue origin. Modern Pathology. 2010: 23, 814 -823.
6. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462-469.
7. Rosenwald S, Meiri E, Gilad S, et al. MicroRNA signature identifies tissue origin of primary and metastatic tumors. Presented at: 44th American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2008; Chicago, IL. Abstract 11028.

1. Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations.
   APMIS. 2003;111(12):1089-1094.
2. Hainsworth JD, Greco A. Treatment of patients with cancer of an unknown primary site.
   N Engl J Med. 1993;329(4):257-263.
3. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer.
   Cancer. 2004;100(9):1776-1785.